Guidelines : Diabetes Mellitus
Detail
Condition :
Diabetes Mellitus
Keywords :
Sulphonylureas, gliptins, GLP-1, biguanides, insulin, blood glucose monitoring, SMBG, self monitoring of blood glucose, hypoglyceamia, Type II, SICK day rule, TREND,
BNF Codes :
Committee Recommendations
Date
Committee Name
Narrative
Traffic Light Status
07 February 2018
Please see the attached Type 2 Diabetes treatment guidelines and associated documentation. See attached documents for further information.
See Below
Documents
Type
Document
Review Date
Supplementary documents (CCG specific documents)
Relevant For
Type
Document
Review Date
NW Surrey CCG
Guidelines (Local)
Friday, May 1, 2020
G&W CCG, NW Surrey CCG, Surrey Downs CCG
Care Home Resources
Monday, February 1, 2021
Drugs
Below are listed drugs that are used to treat Diabetes Mellitus.
- Acarbose Green (see narrative)
- Albiglutide
- Alogliptin Do not initiate in new patients
- Canagliflozin
- Dapagliflozin See narrative
- Degludec Blue
- Dulaglutide Green
- Empagliflozin Green
- Ertugliflozin Green
- Exenatide
- Exenatide plus insulin Amber
- Glibenclamide
- Gliclazide Green
- Gliclazide (Modified Release)
- Glimepiride
- Glipizide
- Glyxambi (Linagliptin/empagliflozin)
- Insulin Aspart See narrative
- Insulin aspart (Fiasp) Blue
- Insulin Detemir Green
- Insulin Glargine Green
- Insulin Glargine (Toujeo - 300 units/ml) - in Type I diabetes Amber Star
- Insulin Glargine (Toujeo - 300 units/ml) - in Type II diabetes Amber Star
- Insulin Glulisine Green
- Insulin Lispro See narrative
- Insulin pump - non-autoimmune causes Red
- Insulin pump - Type 1 diabetes See narrative
- Linagliptin Green (see narrative)
- Liraglutide Green (see narrative)
- Liraglutide plus insulin Amber
- Lixisenatide Green (see narrative)
- Metformin Green (see narrative)
- Needle-free insulin devices Amber Star
- Pioglitazone Green
- Repaglinide
- Saxagliptin Do not initiate in new patients
- Semaglutide (injection) See narrative
- Semaglutide (oral) See narrative
- Sitagliptin Green
- Sotagliflozin
- Suliqua (Insulin glargine/lixisenatide)
- Tirzepatide Green (see narrative)
- Tolbutamide
- Vildagliptin Do not initiate in new patients
- Xultophy See narrative